search
Back to results

Regimens of Intermittent Occlusion Therapy for Amblyopia in Children

Primary Purpose

Amblyopia

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
IO-therapy Glasses
Sponsored by
Salus University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Amblyopia

Eligibility Criteria

3 Years - 8 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

The following criteria must be met for the patient to be enrolled in the study:

  1. Age 3 to < 8 years
  2. Unilateral amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both

    Criteria for strabismus: At least one of the following criteria must be met:

    • Heterotropia at distance and/or near fixation on examination (with or without spectacles)
    • History of strabismus surgery
    • Documented history of strabismus which is no longer present (which in the judgment of the investigator could have caused amblyopia)

    Criteria for anisometropia: At least one of the following criteria must be met:

    • >0.50 D difference between eyes in spherical equivalent
    • >0.50 D difference between eyes in astigmatism in any meridian
  3. Amblyopic eye has no myopia (> -0.25 D spherical equivalent).
  4. Visual acuity, measured in each eye without cycloplegia within 7 days prior to enrollment using the ATS single-surround HOTV letter protocol as follows:

    • Visual acuity in the amblyopic eye between 20/40 and 20/80 inclusive
    • Visual acuity in the sound eye 20/32 or better
    • Inter-eye acuity difference ≥ 2 logMAR lines (i.e., amblyopic eye acuity at least 2 lines worse than sound eye acuity)
  5. No previous amblyopia treatment within 6 months.
  6. Spectacle correction (if applicable) for measurement of enrollment visual acuity must meet the following criteria and be based on a cycloplegic refraction within 6 months:

    • Requirements for spectacle correction:
    • For patients meeting criteria for only strabismus

      • Hypermetropia if corrected must not be undercorrected by more than +1.50 D spherical equivalent, and the reduction in plus sphere must be symmetric in the two eyes. Otherwise, spectacle correction is at investigator discretion.
    • For patients meeting criteria for anisometropia or combined-mechanism

      • Spherical equivalent must be within 0.50 D of fully correcting the anisometropia
      • Hypermetropia must not be undercorrected by more than +1.50 D spherical equivalent, and reduction in plus must be symmetric in the two eyes
      • Cylinder power in both eyes must be within 0.50 D of fully correcting the astigmatism
      • Cylinder axis in the spectacle lenses in both eyes must be within 6 degrees of the axis of the cycloplegic refraction

    Spectacles meeting above criteria must be worn either:

    • for 4 weeks immediately prior to enrollment, or
    • until visual acuity in amblyopic eye is stable (defined as two consecutive visual acuity measurements at least 4 weeks apart with no improvement of one line or more)
    • An acuity measurement done any of the following ways may be considered the first of two consecutive measurements:

      • in current glasses,
      • in trial frames with full correction of hypermetropia with cycloplegia, or
      • in new glasses.
  7. Wearing optimal spectacle correction for a minimum of 4 weeks at the time of enrollment.
  8. Ocular examination within 6 months prior to enrollment.
  9. Gestational age > 34 weeks and birth weight > 1500 grams
  10. Parent willing to accept randomization
  11. Parent willing to be contacted and has access to phone
  12. Parent does not anticipate relocation outside area within study period.

Exclusion Criteria:

  1. Amblyopic eye has myopia worse than -3.00 D spherical equivalent.
  2. Prior intraocular or refractive surgery
  3. Ocular pathologies that impact vision
  4. Cognitive impairment that prohibits accurate data collection

Sites / Locations

  • Salus University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intense 12-hour IO-therapy Group

Standard 4-hour IO-therapy Group

Arm Description

Participants wear 12-hour daily IO-therapy glasses for 4 weeks

Participants wear 4-hour daily IO-therapy glasses for 12 weeks

Outcomes

Primary Outcome Measures

Visual Acuity Improvement
visual acuity difference between the primary outcome measure and baseline in the amblyopic eye; visual acuity was measured with ATS- HOTV method

Secondary Outcome Measures

Stereoacuity Test
Stereoacuity in arcsec was converted to log scale. so log10(stereo) will be reported. The higher value indicates a poorer binocular visual function.
Objective Total Treatment Hours
Objective total treatment hours at the primary outcome visit measured with a microsensor
Objective Adherence
objective adherence measured with a microsensor to the treatment regimen

Full Information

First Posted
May 8, 2016
Last Updated
July 18, 2022
Sponsor
Salus University
search

1. Study Identification

Unique Protocol Identification Number
NCT02767856
Brief Title
Regimens of Intermittent Occlusion Therapy for Amblyopia in Children
Official Title
Intense vs Standard Regimens of Intermittent Occlusion Therapy for Unilateral Moderate Amblyopia in Children
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Terminated
Why Stopped
PI changed the institution.
Study Start Date
September 2016 (Actual)
Primary Completion Date
May 30, 2021 (Actual)
Study Completion Date
May 30, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Salus University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is designed to answer the question: What if the Intermittent Occlusion (IO-therapy) glasses were prescribed all day (12-hours) in which the total time of treatment only took 4 weeks instead of the current treatment time (4 hours) in which it takes 12 weeks? Children aged 3- to 8-years with untreated moderate unilateral amblyopia will be enrolled and randomized into 2 groups: 1) Intense 12-hour IO-therapy Group for 4 weeks treatment; or 2) Standard 4-hour IO-therapy glasses Group for 12 weeks treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amblyopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
32 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intense 12-hour IO-therapy Group
Arm Type
Experimental
Arm Description
Participants wear 12-hour daily IO-therapy glasses for 4 weeks
Arm Title
Standard 4-hour IO-therapy Group
Arm Type
Active Comparator
Arm Description
Participants wear 4-hour daily IO-therapy glasses for 12 weeks
Intervention Type
Device
Intervention Name(s)
IO-therapy Glasses
Primary Outcome Measure Information:
Title
Visual Acuity Improvement
Description
visual acuity difference between the primary outcome measure and baseline in the amblyopic eye; visual acuity was measured with ATS- HOTV method
Time Frame
4 weeks for the Intense Group and 12 weeks for the Standard Group
Secondary Outcome Measure Information:
Title
Stereoacuity Test
Description
Stereoacuity in arcsec was converted to log scale. so log10(stereo) will be reported. The higher value indicates a poorer binocular visual function.
Time Frame
4 weeks for the Intense Group and 12 weeks for the Standard Group
Title
Objective Total Treatment Hours
Description
Objective total treatment hours at the primary outcome visit measured with a microsensor
Time Frame
4 weeks for the Intense Group and 12 weeks for the Standard Group
Title
Objective Adherence
Description
objective adherence measured with a microsensor to the treatment regimen
Time Frame
4 weeks for the Intense Group and 12 weeks for the Standard Group

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The following criteria must be met for the patient to be enrolled in the study: Age 3 to < 8 years Unilateral amblyopia associated with strabismus (comitant or incomitant), anisometropia, or both Criteria for strabismus: At least one of the following criteria must be met: Heterotropia at distance and/or near fixation on examination (with or without spectacles) History of strabismus surgery Documented history of strabismus which is no longer present (which in the judgment of the investigator could have caused amblyopia) Criteria for anisometropia: At least one of the following criteria must be met: >0.50 D difference between eyes in spherical equivalent >0.50 D difference between eyes in astigmatism in any meridian Amblyopic eye has no myopia (> -0.25 D spherical equivalent). Visual acuity, measured in each eye without cycloplegia within 7 days prior to enrollment using the ATS single-surround HOTV letter protocol as follows: Visual acuity in the amblyopic eye between 20/40 and 20/80 inclusive Visual acuity in the sound eye 20/32 or better Inter-eye acuity difference ≥ 2 logMAR lines (i.e., amblyopic eye acuity at least 2 lines worse than sound eye acuity) No previous amblyopia treatment within 6 months. Spectacle correction (if applicable) for measurement of enrollment visual acuity must meet the following criteria and be based on a cycloplegic refraction within 6 months: Requirements for spectacle correction: For patients meeting criteria for only strabismus Hypermetropia if corrected must not be undercorrected by more than +1.50 D spherical equivalent, and the reduction in plus sphere must be symmetric in the two eyes. Otherwise, spectacle correction is at investigator discretion. For patients meeting criteria for anisometropia or combined-mechanism Spherical equivalent must be within 0.50 D of fully correcting the anisometropia Hypermetropia must not be undercorrected by more than +1.50 D spherical equivalent, and reduction in plus must be symmetric in the two eyes Cylinder power in both eyes must be within 0.50 D of fully correcting the astigmatism Cylinder axis in the spectacle lenses in both eyes must be within 6 degrees of the axis of the cycloplegic refraction Spectacles meeting above criteria must be worn either: for 4 weeks immediately prior to enrollment, or until visual acuity in amblyopic eye is stable (defined as two consecutive visual acuity measurements at least 4 weeks apart with no improvement of one line or more) An acuity measurement done any of the following ways may be considered the first of two consecutive measurements: in current glasses, in trial frames with full correction of hypermetropia with cycloplegia, or in new glasses. Wearing optimal spectacle correction for a minimum of 4 weeks at the time of enrollment. Ocular examination within 6 months prior to enrollment. Gestational age > 34 weeks and birth weight > 1500 grams Parent willing to accept randomization Parent willing to be contacted and has access to phone Parent does not anticipate relocation outside area within study period. Exclusion Criteria: Amblyopic eye has myopia worse than -3.00 D spherical equivalent. Prior intraocular or refractive surgery Ocular pathologies that impact vision Cognitive impairment that prohibits accurate data collection
Facility Information:
Facility Name
Salus University
City
Elkins Park
State/Province
Pennsylvania
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32345348
Citation
Wang J, Malik A, Jin J, Pang Y, Yin K, Allen M, Grigorian A, Scombordi B, Bailey J, Aljohani S, Funari K, Shoge R, Meiyeppen S, Myung J, Soni A, Neely DE. Intense versus standard regimens of intermittent occlusion therapy for unilateral moderate amblyopia in children: study protocol for a randomized controlled trial. Trials. 2020 Apr 28;21(1):361. doi: 10.1186/s13063-020-04284-4.
Results Reference
derived

Learn more about this trial

Regimens of Intermittent Occlusion Therapy for Amblyopia in Children

We'll reach out to this number within 24 hrs